Johnson & Johnson’s selection of Alex Gorsky as its seventh chief executive suggests the pharma company will not make its consumer business a higher priority.
Gorsky will succeed CEO William Weldon in April. Like Weldon, the 51-year-old Gorsky’s experience comprises management of Rx pharmaceutical and medical-device businesses
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?